BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 30459406)

  • 1. Novel AR-12 derivatives, P12-23 and P12-34, inhibit flavivirus replication by blocking host de novo pyrimidine biosynthesis.
    Yang CF; Gopula B; Liang JJ; Li JK; Chen SY; Lee YL; Chen CS; Lin YL
    Emerg Microbes Infect; 2018 Nov; 7(1):187. PubMed ID: 30459406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of dengue virus through suppression of host pyrimidine biosynthesis.
    Wang QY; Bushell S; Qing M; Xu HY; Bonavia A; Nunes S; Zhou J; Poh MK; Florez de Sessions P; Niyomrattanakit P; Dong H; Hoffmaster K; Goh A; Nilar S; Schul W; Jones S; Kramer L; Compton T; Shi PY
    J Virol; 2011 Jul; 85(13):6548-56. PubMed ID: 21507975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses.
    Luthra P; Naidoo J; Pietzsch CA; De S; Khadka S; Anantpadma M; Williams CG; Edwards MR; Davey RA; Bukreyev A; Ready JM; Basler CF
    Antiviral Res; 2018 Oct; 158():288-302. PubMed ID: 30144461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AR-12 suppresses dengue virus replication by down-regulation of PI3K/AKT and GRP78.
    Chen HH; Chen CC; Lin YS; Chang PC; Lu ZY; Lin CF; Chen CL; Chang CP
    Antiviral Res; 2017 Jun; 142():158-168. PubMed ID: 28238876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-flavivirus activity of polyoxometalate.
    Qi Y; Han L; Qi Y; Jin X; Zhang B; Niu J; Zhong J; Xu Y
    Antiviral Res; 2020 Jul; 179():104813. PubMed ID: 32376449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis.
    Hoffmann HH; Kunz A; Simon VA; Palese P; Shaw ML
    Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5777-82. PubMed ID: 21436031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The celecoxib derivative kinase inhibitor AR-12 (OSU-03012) inhibits Zika virus via down-regulation of the PI3K/Akt pathway and protects Zika virus-infected A129 mice: A host-targeting treatment strategy.
    Chan JF; Zhu Z; Chu H; Yuan S; Chik KK; Chan CC; Poon VK; Yip CC; Zhang X; Tsang JO; Zou Z; Tee KM; Shuai H; Lu G; Yuen KY
    Antiviral Res; 2018 Dec; 160():38-47. PubMed ID: 30326204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication.
    Luganini A; Sibille G; Mognetti B; Sainas S; Pippione AC; Giorgis M; Boschi D; Lolli ML; Gribaudo G
    Antiviral Res; 2021 May; 189():105057. PubMed ID: 33716051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral activity of the natural alkaloid anisomycin against dengue and Zika viruses.
    Quintana VM; Selisko B; Brunetti JE; Eydoux C; Guillemot JC; Canard B; Damonte EB; Julander JG; Castilla V
    Antiviral Res; 2020 Apr; 176():104749. PubMed ID: 32081740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral Activity of Compound L3 against Dengue and Zika Viruses In Vitro and In Vivo.
    Chuang FK; Liao CL; Hu MK; Chiu YL; Lee AR; Huang SM; Chiu YL; Tsai PL; Su BC; Chang TH; Lin CC; Shih CC; Yen LC
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses.
    Yang CC; Hu HS; Lin HM; Wu PS; Wu RH; Tian JN; Wu SH; Tsou LK; Song JS; Chen HW; Chern JH; Chen CT; Yueh A
    Antiviral Res; 2019 Dec; 172():104636. PubMed ID: 31654671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the in vitro potential of celecoxib derivative AR-12 as an effective antiviral compound against four dengue virus serotypes.
    Hassandarvish P; Oo A; Jokar A; Zukiwski A; Proniuk S; Abu Bakar S; Zandi K
    J Antimicrob Chemother; 2017 Sep; 72(9):2438-2442. PubMed ID: 28666323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory Compound Shows Therapeutic Safety and Efficacy against Flavivirus Infection.
    Chuang FK; Huang SM; Liao CL; Lee AR; Lien SP; Chiu YL; Chang TH; Tsai PL; Lin RJ; Shih CC; Tsai YJ; Lin GJ; Yen LC
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31636070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decanoyl-Arg-Val-Lys-Arg-Chloromethylketone: An Antiviral Compound That Acts against Flaviviruses through the Inhibition of Furin-Mediated prM Cleavage.
    Imran M; Saleemi MK; Chen Z; Wang X; Zhou D; Li Y; Zhao Z; Zheng B; Li Q; Cao S; Ye J
    Viruses; 2019 Oct; 11(11):. PubMed ID: 31683742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule grp94 inhibitors block dengue and Zika virus replication.
    Rothan HA; Zhong Y; Sanborn MA; Teoh TC; Ruan J; Yusof R; Hang J; Henderson MJ; Fang S
    Antiviral Res; 2019 Nov; 171():104590. PubMed ID: 31421166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A MicroRNA Screen Identifies the Wnt Signaling Pathway as a Regulator of the Interferon Response during Flavivirus Infection.
    Smith JL; Jeng S; McWeeney SK; Hirsch AJ
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RPLP1 and RPLP2 Are Essential Flavivirus Host Factors That Promote Early Viral Protein Accumulation.
    Campos RK; Wong B; Xie X; Lu YF; Shi PY; Pompon J; Garcia-Blanco MA; Bradrick SS
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27974556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stearoyl-CoA desaturase-1 is required for flavivirus RNA replication.
    Hishiki T; Kato F; Nio Y; Watanabe S; Wen Tan NW; Yamane D; Miyazaki Y; Lin CC; Suzuki R; Tajima S; Lim CK; Saijo M; Hijikata M; Vasudevan SG; Takasaki T
    Antiviral Res; 2019 May; 165():42-46. PubMed ID: 30853381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Small-Molecule Oligosaccharyltransferase Inhibitor with Pan-flaviviral Activity.
    Puschnik AS; Marceau CD; Ooi YS; Majzoub K; Rinis N; Contessa JN; Carette JE
    Cell Rep; 2017 Dec; 21(11):3032-3039. PubMed ID: 29241533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of drug candidates for broad-spectrum antiviral therapy targeting cellular pyrimidine biosynthesis.
    Marschall M; Niemann I; Kosulin K; Bootz A; Wagner S; Dobner T; Herz T; Kramer B; Leban J; Vitt D; Stamminger T; Hutterer C; Strobl S
    Antiviral Res; 2013 Dec; 100(3):640-8. PubMed ID: 24149002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.